Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease (FLM)
Sponsor: HaEmek Medical Center, Israel
Terminated
COVID-19 interrupted the recruitment process and imposed difficulties
Other terminated trials from HaEmek Medical Center, Israel
Listed as NCT03748511, this observational or N/A phase trial focuses on Patients With Fatty Liver Disease and remains terminated or withdrawn. Sponsored by HaEmek Medical Center, Israel, it has been updated 8 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Apr 2023 — Jul 2024 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Mar 2022 — Apr 2023 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Active Not Recruiting
▶ Show 3 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2019 — Mar 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Dec 2018 — Sep 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- HaEmek Medical Center, Israel
For direct contact, visit the study record on ClinicalTrials.gov .